Search - tctmd.com

Displaying 461 - 480 of 1302

Sort: Relevancy | Date

News Daily News

Vorapaxar可以防范意外缺血性卒中、支架内血栓形成

Todd Neale

December 04, 2014

News Daily News

Vorapaxar podría Proteger frente a ACV Isquémicos Incidentales y Trombosis del Stent

Todd Neale

December 04, 2014

News Daily News

Vorapaxar May Protect Against Incident Ischemic Stroke, Stent Thrombosis

Todd Neale

December 04, 2014

News Daily News

PARTNER Registry Documents Strides Made in Transfemoral TAVR

L.A. McKeown

December 04, 2014

Presentation

New Ischemic Stroke and Outcomes With Vorapaxar vs Placebo

Presenter: B.P. Bonaca

December 02, 2014

News Conference News AHA 2014

AVOIDing Oxygen in Suspected STEMI Tied to Smaller Infarcts, Less Recurrent MI

Yael L. Maxwell

November 18, 2014

News Daily News

年龄对接受支架拔出器治疗的急性卒中患者有影响

November 17, 2014

News Daily News

Study Suggests Immature Platelet Count Predicts MACE Risk in CAD

November 17, 2014

News Conference News AHA 2014

Role of CTA in Survival Prediction, Resource Utilization Explored

November 17, 2014

News Conference News AHA 2014

Novel, Efficient CT-based FFR Outperforms CTA

November 17, 2014

News Conference News AHA 2014

Mitral Repair at the Time of CABG Provides No Mortality, QoL Benefit at 1 Year

Yael L. Maxwell

November 17, 2014

News Daily News

Meta-analysis Questions One-Size-Fits-All Anticoagulant Strategy in STEMI Patients

L.A. McKeown

November 17, 2014

News Daily News

La Edad Influye en Pacientes con ACV Agudos Tratados con un Recuperador de Stent

November 17, 2014

News Daily News

Age Matters in Acute Stroke Patients Treated With Stent Retriever

November 17, 2014

News Conference News AHA 2014

Vorapaxar Safe in NSTE-ACS But Bleeding Risk Merits 6-Month Delay Before Noncardiac Surgery

Yael L. Maxwell

November 16, 2014

News Conference News AHA 2014

FACTOR-64: No Benefit to CTA Screening of Asymptomatic Patients with Diabetes

November 16, 2014

News Conference News AHA 2014

Ezetimibe Proves Clinical Benefit on Top of Statin Therapy

November 16, 2014

News Conference News AHA 2014

Long-Term Better than Short-Term Prasugrel After PES Stenting

November 15, 2014

News Conference News AHA 2014

ISAR-SAFE: Another Randomized Trial Finds 6 Months of DAPT as Good as 12 Months

November 15, 2014

News Daily News

Real-World Study Shows Benefits of Treating Culprit Vessel Only in STEMI

Yael L. Maxwell

November 06, 2014

Advertisement

Vorapaxar可以防范意外缺血性卒中、支架内血栓形成

Vorapaxar podría Proteger frente a ACV Isquémicos Incidentales y Trombosis del Stent

Vorapaxar May Protect Against Incident Ischemic Stroke, Stent Thrombosis

PARTNER Registry Documents Strides Made in Transfemoral TAVR

New Ischemic Stroke and Outcomes With Vorapaxar vs Placebo

AVOIDing Oxygen in Suspected STEMI Tied to Smaller Infarcts, Less Recurrent MI

年龄对接受支架拔出器治疗的急性卒中患者有影响

Study Suggests Immature Platelet Count Predicts MACE Risk in CAD

Role of CTA in Survival Prediction, Resource Utilization Explored

Novel, Efficient CT-based FFR Outperforms CTA

Mitral Repair at the Time of CABG Provides No Mortality, QoL Benefit at 1 Year

Meta-analysis Questions One-Size-Fits-All Anticoagulant Strategy in STEMI Patients

La Edad Influye en Pacientes con ACV Agudos Tratados con un Recuperador de Stent

Age Matters in Acute Stroke Patients Treated With Stent Retriever

Vorapaxar Safe in NSTE-ACS But Bleeding Risk Merits 6-Month Delay Before Noncardiac Surgery

FACTOR-64: No Benefit to CTA Screening of Asymptomatic Patients with Diabetes

Ezetimibe Proves Clinical Benefit on Top of Statin Therapy

Long-Term Better than Short-Term Prasugrel After PES Stenting

ISAR-SAFE: Another Randomized Trial Finds 6 Months of DAPT as Good as 12 Months

Real-World Study Shows Benefits of Treating Culprit Vessel Only in STEMI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content